Articles about NanoString

Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process

by Taylor Soper on April 17, 2024April 17, 2024 at 6:06 pm

NanoString announced Wednesday that it will be acquired by Bruker, ending the company’s restructuring process that included a Chapter 11 bankruptcy plan. Bruker, a Massachusetts-based publicly traded life sciences research… Read More

News Brief

Healthcare investment firm Patient Square Capital agrees to acquire NanoString assets for $220M

by Taylor Soper on March 10, 2024March 10, 2024 at 11:15 pm

NanoString, the Seattle-based biotech company that initiated a Chapter 11 bankruptcy process last month, announced late Sunday it agreed to a deal with healthcare investment firm Patient Square Capital.

NanoString stock sinks 70% as Seattle biotech company enters bankruptcy process

by Taylor Soper on February 5, 2024February 6, 2024 at 6:08 am

Seattle-based publicly traded biotech company NanoString Technologies announced Monday that it has initiated a Chapter 11 bankruptcy plan and is exploring a potential sale in the latest fallout from its loss… Read More

NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq

by Taylor Soper on January 6, 2024January 6, 2024 at 8:41 am

Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce. The company also reported that… Read More

NanoString stock sinks nearly 50% after losing patent lawsuit case against 10x Genomics

by Taylor Soper on November 20, 2023November 20, 2023 at 8:48 am

Shares of Seattle-based publicly traded biotech company NanoString Technologies fell nearly 50% to an all-time low on Monday following its loss in a patent infringement case against 10x Genomics. A… Read More

Tech Moves: Esper names CFO; Streem founder steps down; Nanostring adds board member

by Julie Emory on April 18, 2022April 19, 2022 at 7:56 am

— David Barclay, former chief financial officer for DigniFi and Xevo, joined Esper as CFO. Esper is a Seattle-based startup that sells software to remotely manage IoT devices. Founded in… Read More

Tech Moves: Life Science Washington names new CEO; AWS exec departs; Vizio CTO retires

by Cara Kuhlman on January 11, 2022January 11, 2022 at 9:54 am

— Life Science Washington announced Marc Cummings as its new CEO and president. He was most recently the trade association’s VP of public policy and external affairs. Former CEO Leslie… Read More

Tech Moves: Accolade names chief medical officer; Apptio hires marketing lead; Rigado has a new CEO

by James Thorne on November 1, 2019November 1, 2019 at 10:42 am

— Health technology company Accolade landed Dr. Shantanu Nundy as chief medical officer. Nundy formerly worked on digital health initiatives for the World Bank and was director of the nonprofit… Read More

Tech Moves: Algorithmia lands former Atlassian and InfluxData execs; GitHub hires former Google Cloud leader

by James Thorne on October 6, 2019October 7, 2019 at 9:45 am

Rachel Potvin signed on with Microsoft-owned GitHub as vice president of engineering. Potvin most recently led the data insights group at Google Cloud. She previously ran DevOps teams at Google… Read More

Here are the winners and (mostly) losers of Seattle tech stocks in 2018

by James Thorne on January 3, 2019January 3, 2019 at 1:57 pm

Whew! Stocks were all over the place in 2018. Things were going well in late summer, but by fall the wheels were coming off. In December, the market saw more… Read More

Tech Moves: Amazon hires top doc; Geir Hansen leaves SVB; Acumatica board adds ex-Microsoft Business Solutions chief

by Clare McGrane on January 24, 2018January 24, 2018 at 3:29 pm

Amazon is continuing to bolster its health care game. The company recently hired Dr. Martin Levine, a longtime Seattle doctor and leader of Iora Health‘s Seattle area operations, according to… Read More

Biotechnology company NanoString partners with Merck to create test for anti-cancer drug

by Madeline Vuong on February 29, 2016February 29, 2016 at 2:57 pm

NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to different cancer therapies, announced today that it will join pharmaceutical… Read More

NanoString Technologies misses estimates as losses deepen

by Blair Hanley Frank on May 6, 2015May 6, 2015 at 4:21 pm

NanoString Technologies, a Seattle-based biotech company focused on developing cancer treatments, faced deepening losses this quarter as the company missed analyst expectations. The company reported a net loss of $14.9… Read More

The best and worst performing tech stocks of 2014 in the Seattle area

by John Cook on January 1, 2015January 1, 2015 at 4:20 pm

It was a busy year for publicly-traded tech companies in the Seattle region, with plenty of winners and losers. The region’s two heavyweight tech titans produced opposite results on Wall… Read More

NanoString expands office and lab space

by John Cook on December 24, 2014December 24, 2014 at 8:13 am

NanoString, a 12-year-old Seattle company whose tools help genetic researchers better analyze genes and molecules, is expanding its footprint in the South Lake Union neighborhood. The company announced today that… Read More

NanoString chief medical officer J. Wayne Cowens passes away at the age of 67

by John Cook on August 27, 2014August 27, 2014 at 7:23 am

Dr. J. Wayne Cowens, the chief medical officer at Seattle-based NanoString Technologies, has died at the age of 67. “We are shocked and deeply saddened by the sudden loss of… Read More

Nanostring posts record revenue of $10.9M, up 51% from last year

by Taylor Soper on August 5, 2014September 1, 2014 at 9:47 am

NanoString Technologies, a provider of life science tools for research and molecular diagnostic products, beat Wall Street’s expectations with a record $10.9M in revenue for the second quarter, which was up… Read More

NanoString files for $55M stock offering, expects 37% revenue growth for 2013

by John Cook on January 13, 2014January 13, 2014 at 8:00 am

NanoString Technologies, a provider of life science tools for research and molecular diagnostic products, has filed to raise $55 million through a secondary stock offering. The filing comes seven months… Read More

Nanostring IPO disappoints as shares fall 20% on first day

by Taylor Soper on June 26, 2013June 26, 2013 at 6:29 pm

It was a tough first day on the stock market for Seattle’s NanoString Technologies, with shares falling 19.4 percent on Wednesday as the stock closed at $8.06. The 138-person company, a maker of… Read More

NanoString sets IPO range of $13-$15, plans to trade on Nasdaq under ticker NSTG

by John Cook on June 13, 2013June 13, 2013 at 7:56 am

Seattle’s NanoString Technologies today set the terms for its upcoming initial public offering, with plans to sell shares in the range of $13 to $15 per share. The 138-person company, a… Read More

NanoString lands $15.3M for genetic analysis system

by John Cook on December 3, 2012December 3, 2012 at 4:56 pm

NanoString Technologies continues to rake in new capital, announcing today that it has raised $15.3 million from Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. Existing investors, including Clarus Ventures,… Read More

NanoString